Table 2.

Summary of the primary outcomes

	Fexofenadine group n = 30	Control group n = 31	P value 0 (between groups)
UACR (mg/g)
Mean baseline	260 ± 53	248 ± 80	0.5
Mean after 6 months	215 ± 58	272 ± 85	0.004*
Percent change between the 2 points	− 16%	11%	< 0.001*
P value (within groups)	< 0.001*	0.004*
eGFR (mL/min/1.73 m2)
Mean baseline	82.5 ± 11.6	82.1 ± 18.5	0.92
Mean after 6 months	81.2 ± 12	78.3 ± 14	0.38
Percent change between the 2 points	− 1.5%	− 3.5%	0.31
P value (within groups)	0.144	0.016*

Values are expressed as mean ± SD. UACR urinary albumin to creatinine ratio, eGFR estimated glomerular filtration rate

*Significant difference (P < 0.05)